
p16INK4a is a Prognostic Marker in Resected Ductal Pancreatic Cancer
Author(s) -
Berthold Gerdes,
Annette Ramaswamy,
Andreas Ziegler,
Sven A. Lang,
Michael Kersting,
Renate Baumann,
Anja Wild,
Roland Moll,
M. Rothmund,
Detlef K. Bartsch
Publication year - 2002
Publication title -
annals of surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.153
H-Index - 309
eISSN - 1528-1140
pISSN - 0003-4932
DOI - 10.1097/00000658-200201000-00007
Subject(s) - medicine , mdm2 , oncology , cancer research , cancer , methylation , clinical significance , pancreatic cancer , tumor suppressor gene , cell cycle , pathology , gene , carcinogenesis , biology , biochemistry
To identify the prognostic relevance of the G1/S cell cycle regulator genes p16INK4a, p53, MDM2, and Rb in patients with resected ductal pancreatic cancer (PC).